Skip to main content
. 2021 Jul 28;137(5):888–900. doi: 10.1177/00333549211029971

Table 4.

Linkage to HIV medical care a within 1 month of HIV diagnosis, by education level of county of residence, among adults aged ≥18, by sex at birth and selected characteristics, 41 states b and the District of Columbia, 2017 c

Characteristic Residence in counties where ≥13% of population has <high school diploma Residence in counties where <13% of population has <high school diploma Prevalence ratiod (95% CI)
Total diagnoses, no. Linked to care within 1 month, no. (%) Not linked to care within 1 month, no. (%) Total diagnoses, no. Linked to care within 1 month, no. (%) Not linked to care within 1 month, no. (%)
Males
Age at diagnosis, y
 18-24 2974 2192 (73.7) 782 (26.3) 3063 2309 (75.4) 754 (24.6) 0.98 (0.95-1.01)
 25-34 4990 3810 (76.4) 1180 (23.6) 5025 3934 (78.3) 1091 (21.7) 0.98 (0.95-1.00)
 35-44 2550 2020 (79.2) 530 (20.8) 2372 1945 (82.0) 427 (18.0) 0.97 (0.94-0.99)
 45-54 1768 1391 (78.7) 377 (21.3) 1884 1591 (84.4) 293 (15.6) 0.93 (0.90-0.96)
 ≥55 1087 888 (81.7) 199 (18.3) 1215 993 (81.7) 222 (18.3) 1.00 (0.96-1.04)
Race/ethnicity
 American Indian/Alaska Native 62 52 (83.9) 10 (16.1) 59 49 (83.1) 10 (16.9) 1.01 (0.86-1.18)
 Asian 336 255 (75.9) 81 (24.1) 412 353 (85.7) 59 (14.3) 0.89 (0.82-0.95)
 Black/African American 4961 3711 (74.8) 1250 (25.2) 5654 4208 (74.4) 1446 (25.6) 1.01 (0.98-1.03)
 Hispanic/Latino e 4820 3750 (77.8) 1070 (22.2) 2618 2146 (82.0) 472 (18.0) 0.95 (0.93-0.97)
 Native Hawaiian/Other Pacific Islander 9 7 (77.8) 2 (22.2) 24 21 (87.5) 3 (12.5) 0.89 (0.61-1.30)
 White 2870 2279 (79.4) 591 (20.6) 4376 3658 (83.6) 718 (16.4) 0.95 (0.93-0.97)
 Multiple races 311 247 (79.4) 64 (20.6) 416 337 (81.0) 79 (19.0) 0.98 (0.91-1.05)
Transmission category f
 Male-to-male sexual contact 11 233 8682 (77.3) 2551 (22.7) 11 029 8814 (79.9) 2215 (20.1) 0.97 (0.95-0.98)
 Injection drug use 504 377 (74.9) 127 (25.1) 563 438 (77.8) 125 (22.2) 0.96 (0.90-1.03)
 Male-to-male sexual contact and injection drug use 465 337 (72.4) 128 (27.6) 629 490 (77.8) 140 (22.2) 0.93 (0.87-0.99)
 Heterosexual contact g 1155 895 (77.5) 260 (22.5) 1325 1021 (77.0) 305 (23.0) 1.01 (0.96-1.05)
 Other h 12 10 (80.6) 2 (19.4) 13 10 (79.1) 3 (20.9) 1.02 (0.69-1.51)
County of residence at diagnosis (population)
 Metropolitan (≥500 000) 10 645 8231 (77.3) 2414 (22.7) 11 296 8987 (79.6) 2309 (20.4) 0.97 (0.96-0.99)
 Urban (50 000-499 999) 1538 1167 (75.9) 371 (24.1) 1866 1457 (78.1) 409 (21.9) 0.97 (0.94-1.01)
 Rural (<50 000) 1186 903 (76.1) 283 (23.9) 397 328 (82.6) 69 (17.4) 0.92 (0.87-0.97)
Subtotal 13 369 10 301 (77.1) 3068 (22.9) 13 559 10 772 (79.4) 2787 (20.6) 0.97 (0.96-0.98)
Females
Age at diagnosis, y
 18-24 402 304 (75.6) 98 (24.4) 416 323 (77.6) 93 (22.4) 0.97 (0.90-1.05)
 25-34 846 651 (77.0) 195 (23.0) 880 711 (80.8) 169 (19.2) 0.95 (0.91-1.00)
 35-44 709 550 (77.6) 159 (22.4) 767 590 (76.9) 177 (23.1) 1.01 (0.95-1.07)
 45-54 584 466 (79.8) 118 (20.2) 648 532 (82.1) 116 (17.9) 0.97 (0.92-1.03)
 ≥55 462 361 (78.1) 101 (21.9) 562 472 (84.0) 90 (16.0) 0.93 (0.88-0.99)
Race/ethnicity
 American Indian/Alaska Native 17 14 (82.4) 3 (17.6) 19 18 (94.7) 1 (5.3) 0.87 (0.68-1.11)
 Asian 36 22 (61.1) 14 (38.9) 61 51 (83.6) 10 (16.4) 0.73 (0.55-0.97)
 Black/African American 1830 1419 (77.5) 411 (22.5) 1965 1576 (80.2) 389 (19.8) 0.97 (0.94-0.99)
 Hispanic/Latino e 590 474 (80.3) 116 (19.7) 368 292 (79.3) 76 (20.7) 1.01 (0.95-1.08)
 Native Hawaiian/Other Pacific Islander 2 2 (100.0) 0 8 6 (75.0) 2 (25.0)
 White 464 353 (76.1) 111 (23.9) 766 612 (79.9) 154 (20.1) 0.95 (0.89-1.01)
 Multiple races 64 48 (75.0) 16 (25.0) 86 73 (84.9) 13 (15.1) 0.88 (0.75-1.04)
Transmission category f
 Injection drug use 382 296 (77.6) 86 (22.4) 460 350 (76.2) 109 (23.8) 1.02 (0.94-1.10)
 Heterosexual contact g 2610 2028 (77.7) 582 (22.3) 2798 2264 (80.9) 534 (19.1) 0.96 (0.93-0.99)
 Other h 11 8 (72.3) 3 (27.7) 15 14 (90.8) 1 (9.2) 0.80 (0.54-1.18)
County of residence at diagnosis (population)
 Metropolitan (≥500 000) 2240 1741 (77.7) 499 (22.3) 2743 2197 (80.1) 546 (19.9) 0.97 (0.94-0.99)
 Urban (50 000-499 999) 441 341 (77.3) 100 (22.7) 453 375 (82.8) 78 (17.2) 0.93 (0.87-0.99)
 Rural (<50 000) 322 250 (77.6) 72 (22.4) 77 56 (72.7) 21 (27.3) 1.07 (0.92-1.24)
Subtotal 3003 2332 (77.7) 671 (22.3) 3273 2628 (80.3) 645 (19.7) 0.97 (0.94-0.99)
Total 16 372 12 633 (77.2 3739 (22.8) 16 832 13 400 (79.6) 3432 (20.4) 0.97 (0.96-0.98)

aLinkage to HIV medical care was measured by documentation of ≥1 CD4+ T-lymphocyte test or ≥1 viral load test ≤1 month after HIV diagnosis. Of 38 381 people with HIV diagnosed in 2017, 33 204 met inclusion criteria for this analysis.

bAlabama, Alaska, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.

cData source: Cohen et al. 21

dCompares percentage linked to care within 1 month of HIV diagnosis.

eHispanic/Latino can be of any race.

fData were adjusted to account for missing data on transmission category; therefore, values may not sum to column total.

gHeterosexual contact with a person known to have or to be at high risk for HIV infection.

hIncludes people whose infection was attributed to hemophilia blood transfusion or perinatal exposure or whose risk factor was not reported or identified.